Skip to content
News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Dr. C H Weaver MD
January 13, 2026
Zanidatamab Combination May Become New First-Line Option for HER2-Positive Gastroesophageal Cancer
Dr. C H Weaver MD
January 12, 2026
Rucaparib (Rubraca) for Advanced Prostate Cancer
Dr. C H Weaver MD
January 9, 2026
Personalized Colorectal Cancer Care: 2025 Highlights in Testing, Targeted Treatments, and Everyday Management
Dr. C H Weaver MD
January 9, 2026
Gedatolisib Combination Extends Disease Control After CDK4/6 Inhibitors in HR‑Positive, HER2‑Negative, PIK3CA Wild‑Type Advanced Breast Cancer
Dr. C H Weaver MD
January 1, 2026
January Is National Cervical Cancer Awareness Month
Dr. C H Weaver MD
December 31, 2025
10 Ways to Reduce Your Cancer Risk!
Dr. C H Weaver MD
December 31, 2025
Qinlock (Ripretinib) for Advanced Gastrointestinal Stromal Tumors: What Patients Should Know
Dr. C H Weaver MD
December 22, 2025
Rybrevant (Amivantamab) Treatment of EGFR Positive Non-Small Cell Lung Cancer
Dr. C H Weaver MD
December 19, 2025
Pirtobrutinib (Jaypirca) Improves Outcomes for Chronic Lymphocytic Leukemia
Dr. C H Weaver MD
December 19, 2025
The Big Picture: Medical Breakthroughs in 2025
Dr. C H Weaver MD
December 19, 2025
Could Extreme Distance Running Raise Colon Cancer Risk? New Study Highlights a Hidden Concern for Younger Athletes
Dr. C H Weaver MD
December 19, 2025
Tucatinib (Tukysa) Combination May Help People With HER2+ Metastatic Breast Cancer Stay in Remission Longer
Dr. C H Weaver MD
Previous Page
1
…
4
5
6
7
8
…
383
Next Page
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
